MedTrace Logo

Efficacy of a Digital Therapeutic for People With Dysarthria After Stroke

NCT05146765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-12-20

No results posted yet for this study

Summary

This pilot trial will establish the feasibility of a new digitized speech rehabilitation developed for patients with post-stroke dysarthria. For this study, participants will be instructed to use the speech therapy app for 30 minutes to 1 hour per day over a 4-week period.

Conditions

  • Dysarthria as Late Effect of Stroke

Interventions

DEVICE

Mobile application

Device: Use of mobile application Participants will be instructed to use the speech therapy app for 30 minutes to one hour per day over a 4-week period.

OTHER

Treatment as usual

The patients will follow the treatment as usual, including conventional stroke therapy if needed based on the medical guidelines.

Sponsors & Collaborators

  • Ewha Womans University Seoul Hospital

    lead OTHER

Principal Investigators

  • Tae-Jin Song, MD, PhD · Department of Neurology, Ewha University College of Medicine, Seoul, Republic of Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2022-08-30
Completion
2022-08-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05146765 on ClinicalTrials.gov